Clinical trial
A Single Arm, Single Dose Study to Evaluate the Effect of Intravitreal Dexamethasone Implant (Ozurdex®) on Hard Exudates of Diabetic Macular Edema
NCT02399657 is registered in ClinicalTrials.gov with Inje University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Arm, Single Dose Study to Evaluate the Effect of Intravitreal Dexamethasone Implant (Ozurdex®) on Hard Exudates of Diabetic Macular Edema
- Lead sponsor
- Inje University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- February 28, 2015
- Completion date
- December 31, 2016
- Enrollment
- 48 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, macular edema, retinal exudates and deposits